The Endocannabinoid System as a Therapeutic Target in Glaucoma

Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attract...

Descripción completa

Detalles Bibliográficos
Autores principales: Cairns, Elizabeth A., Baldridge, William H., Kelly, Melanie E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737462/
https://www.ncbi.nlm.nih.gov/pubmed/26881140
http://dx.doi.org/10.1155/2016/9364091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737462/
https://www.ncbi.nlm.nih.gov/pubmed/26881140
http://dx.doi.org/10.1155/2016/9364091

Ejemplares similares